Mineralys Therapeutics Appoints Minji Kim, Ph.D. as Chief Business Officer

Go back to Mineralys Therapeutics Appoints Minji Kim, Ph.D. as Chief Business Officer
(NASDAQ: MLYS) Delayed: 29.04 +3.47 (13.57%)
Previous Close $25.57    52 Week High
Open $25.70    52 Week Low
Day High $29.29    P/E N/A 
Day Low $25.70    EPS
Volume 2,038,871